JNJ-70033093 (BMS-986177)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for JNJ-70033093 (BMS-986177), covering 2025-03-30 to 2025-04-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study of JNJ-70033093 (BMS-986177) in Healthy Adult Participants [Phase 1]